Viamet Appoints Dr. Volker Herrmann As Chief Commercial Officer

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Viamet Pharmaceuticals, Inc. today announced the appointment of Volker Herrmann, M.D., M.B.A., as Chief Commercial Officer. Dr. Hermann is an accomplished pharmaceutical executive with extensive experience in sales, marketing, commercial strategy and market access. Prior to joining Viamet, Dr. Herrmann served as Head of Global Strategy, Commercial Development & Global Marketing for the Vaccines Business Unit of Pfizer Inc. At Pfizer, he contributed to the successful performance of several of the most significant brands in the pharmaceutical marketplace.

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.